SCHEMBL30835527

SCHEMBL30835527

CC(C)(C[C@H](NC(=O)c1ccc(NCc2cnc3nc(N)[nH]c(=O)c3n2)cc1)C(=O)O)C(=O)O

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 4/20 0.77
▸ TYMS P04818 3/20 0.77
▸ KDM4E B2RXH2 1/20 0.77
▸ MEN1 O00255 1/20 0.77
▸ ALDH1A1 P00352 1/20 0.77
▸ POLB P06746 1/20 0.77
▸ GAA P10253 1/20 0.77
▸ HPGD P15428 1/20 0.77
▸ TSHR P16473 1/20 0.77
▸ PTGS2 P35354 1/20 0.77
▸ KMT2A Q03164 1/20 0.77
▸ HSD17B10 Q99714 1/20 0.77
▸ TDP1 Q9NUW8 1/20 0.77
▸ ADORA3 P0DMS8 1/20 0.56
▸ DHFR P00374 5/20 0.55
▸ GART P22102 2/20 0.51
▸ ATIC P31939 1/20 0.51
▸ NOS1 P29475 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30749414 1.00 AKR1B1 (0.77) AKR1B1TYMSKDM4EMEN1ALDH1A1
SCHEMBL15864552 1.00 AKR1B1 (0.77) AKR1B1TYMSKDM4EMEN1ALDH1A1
SCHEMBL31121836 0.93 TYMS (0.75) AKR1B1TYMSKDM4EMEN1ALDH1A1
SCHEMBL27532324 0.93 AKR1B1 (0.75) AKR1B1TYMSKDM4EMEN1ALDH1A1
SCHEMBL10531183 0.92 TYMS (0.77) AKR1B1TYMSKDM4EMEN1ALDH1A1
SCHEMBL29783453 0.91 TYMS (0.76) AKR1B1TYMSKDM4EMEN1ALDH1A1
SCHEMBL29289320 0.91 TYMS (0.76) AKR1B1TYMSKDM4EMEN1ALDH1A1
SCHEMBL28444343 0.91 TYMS (0.76) AKR1B1TYMSKDM4EMEN1ALDH1A1
SCHEMBL10173120 0.91 AKR1B1 (0.81) AKR1B1TYMSKDM4EMEN1ALDH1A1
SCHEMBL470145 0.91 AKR1B1 (0.81) AKR1B1TYMSKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117683049-A Indole derivatives as RAS inhibitors for the treatment of cancer 锐新医药公司 2024-03-12 — — CN disclosed
Send feedback